AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

TERIFLUNOMIDE

13 registrations across 3 African markets— 12 active

Markets with TERIFLUNOMIDE

🇿🇦South Africa
11 registrations
11 active
🇹🇳Tunisia
1 registration
0 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
TURBAGIO 14
TABLET, COATED; ORAL
🇿🇼ZimbabweINNOVATA PHARMACEUTICALSactiveJul 2030
TERIFLUNOMIDE PD🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveDec 2029
DENOMIDE🇿🇦South AfricaLeBasi Pharmaceuticals (Pty) LtdactiveOct 2029
RELTIF🇿🇦South AfricaLeBasi Pharmaceuticals (Pty) LtdactiveOct 2029
FLUNOVO🇿🇦South AfricaLeBasi Pharmaceuticals (Pty) LtdactiveOct 2029
TERIFLUNOMIDE HETERO🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveAug 2029
TERIFLUNOMIDE 14 mg ASCEND🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveMar 2029
BAGIOCORD🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveJan 2029
TERIFLUNOMIDE ADCO🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
TERITEMSO🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
AUBAGIO
Comprimé pelliculé / 14 mg
🇹🇳TunisiaSanofi Winthrop Industrie .expiredOct 2020
AUBERIF🇿🇦South AfricaSanofi Industries South Africa (Pty) LtdactiveJan 1900
AUBAGIO🇿🇦South AfricaSanofi-Aventis South Africa (Pty) LtdactiveJan 1900

TERIFLUNOMIDE in Africa — Regulatory Overview

TERIFLUNOMIDE is registered across 3 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 12 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.